Feature | TCT | October 11, 2019

TCT 2019 Late-breaking Presentations

DAIC offers the full list of featured late-breaking trials and science presentations at the 2019 Transcatheter Cardiovascular Therapeutics scientific symposium

TCT 2019 Late-breaking Presentations in the main arena. The top interventional cardiology studies of 2019. #TCT #TCT19 #TCT2019

October 10, 2019 — Here are the Cardiovascular Research Foundation (CRF) 12 late-breaking trials and 16 late-breaking science presentations that were reported at the Transcatheter Cardiovascular Therapeutics (TCT) 2019 scientific symposium. TCT, the world’s premier educational meeting specializing in interventional cardiovascular medicine, it took place Sept. 25 – 29, 2019 at The Moscone Center in San Francisco.

Every year, TCT features major medical research breakthroughs and highlights the latest data on the most innovative treatments that will impact patient care and how physicians treat heart disease, the leading cause of death in the world. The studies selected examine the safety and effectiveness of minimally invasive techniques, pharmaceuticals, technologies, and devices that demonstrate potential to treat or prevent cardiovascular disease.

Late-breaking trials and science were presented in the Main Arena and highlighted during press conferences.

 

Overview of top TCT19 trends - 6 Hot Topics in Interventional Cardiology at TCT 2019

Image Gallery From the TCT 2019 Meeting

 

Thursday, Sept. 26, 2019

Late-Breaking Trials

 

Late-Breaking Science

 

Friday, Sept. 27, 2019

Late-Breaking Trials

 

Late-Breaking Science

 

Saturday, Sept. 28, 2019

Late-Breaking Trials

 

Late-Breaking Science

 

Friday, Sept. 29, 2019

Late-Breaking Trials

 

Late-Breaking Science

 

Video Coverage of TCT 2019:

6 Hot Topics in Interventional Cardiology at TCT 2019

VIDEO: SCAI Prospective on Key Takeaways at TCT 2019 — Interview with Chandan Devireddy, M.D.

VIDEO: Cardiogenic Shock Initiative Continues to Reduce Mortality by 50 Percent — Interview with William O’Neill, M.D.

VIDEO: Overview of Short DAPT in High-risk Bleeding Patients Who Receive Stents — Interview with Robert Harrington, M.D.

VIDEO: The Expansion of TAVR Following the FDA Clearing its Use in All Patients — Interview with Torsten Vahl, M.D.

VIDEO: TWILIGHT Trial Shows Benefit to Ticagrelor Monotherapy After Stent Implantation — Interview with Roxana Mehran, M.D.

VIDEO: Highlighting Women Involved With Structural Heart Interventions — Interview with Vivian Ng, M.D.

VIDEO: Early Discontinuation of DAPT in High Bleeding Risk Patients With the Synergy Stent — Interview with Ajay Kirtane, M.D.

VIDEO: Justification for Hemodynamic Support in Complex PCI — Interview with Jeffrey J. Popma, M.D.

VIDEO: New PLATINUM Diversity Data Shows Early DAPT Cessation OK in Minorities With New Generation Stent — Interview with Roxana Mehran, M.D.,

VIDEO: Trends in Radial Access for Percutaneous Coronary Interventions — Interview with Sunil Rao, M.D., and Prashant Kaul, M.D.

 

Other TCT 2019 News:

Positive Safety, Efficacy Data Reported on AccuCinch Heart Failure Device

EchoPixel Introduces 3-D Holographic Intraoperative Software

New Research on Tempo Temporary Pacing Lead to Be Featured at TCT 2019

Supraflex Drug-Eluting Stent Superior to Xience in Two-Year Target Vessel Failure

 

For more information: www.crf.org/tct

 

Related Late-breaking Cardiovascular Trials:

ACC 2019 Late-breaking Presentations

Late-breaking Interventional Cardiology Presentations at SCAI 2019

American Heart Association 2018 Late-breaking Trials

VIVA 2019 Late-breaking Clinical Trials
 

 

 

 

 

#TCT2019

Related Content

News | Cardiovascular Clinical Studies

May 20, 2022 — Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin ...

Home May 20, 2022
Home
News | Cardiovascular Clinical Studies

May 11, 2022 — Hypertrophic cardiomyopathy is a heart disease that leads to a stressed, swollen heart muscle. Due to a ...

Home May 11, 2022
Home
News | Cardiovascular Clinical Studies

May 5, 2022 — High-level results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) reached a ...

Home May 05, 2022
Home
News | Cardiovascular Clinical Studies

April 7, 2022 – Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who ...

Home April 07, 2022
Home
News | Cardiovascular Clinical Studies

April 7, 2022 – While there are effective therapies to reduce the risk of heart disease by lowering low-density ...

Home April 06, 2022
Home
News | Cardiovascular Clinical Studies

March 25, 2022 – Despite recent efforts to improve women’s leadership in cardiovascular clinical trial research over the ...

Home March 25, 2022
Home
News | Cardiovascular Clinical Studies

We are launching something new—a Clinical Case of the Month—and we want you to contribute! Do you have a clinical case ...

Home February 17, 2022
Home
News | Cardiovascular Clinical Studies

February 8, 2022 — A new study is the first to show that a remote cognitive assessment could help with tracking patients ...

Home February 07, 2022
Home
News | Cardiovascular Clinical Studies

June 24, 2021 — Data captured in American College of Cardiology (ACC) National Cardiovascular Data Registry (NCDR) ...

Home June 24, 2021
Home
News | Cardiovascular Clinical Studies

January 27, 2021 — A New York Institute of Technology research team has secured a five-year $1.8 million grant from the ...

Home January 27, 2021
Home
Subscribe Now